Insulin-regulated hepatic gluconeogenesis through FOXO1–PGC-1α interaction
The DOI matches its Crossref record; 23 of the 23 references it cites were found in a registry or an index.
Abstract
Hepatic gluconeogenesis is absolutely required for survival during prolonged fasting or starvation, but is inappropriately activated in diabetes mellitus. Glucocorticoids and glucagon have strong gluconeogenic actions on the liver. In contrast, insulin suppresses hepatic gluconeogenesis. Two components known to have important physiological roles in this process are the forkhead transcription factor FOXO1 (also known as FKHR) and peroxisome proliferative activated receptor-gamma co-activator 1 (PGC-1alpha; also known as PPARGC1), a transcriptional co-activator; whether and how these factors collaborate has not been clear. Using wild-type and mutant alleles of FOXO1, here we show that PGC-1alpha binds and co-activates FOXO1 in a manner inhibited by Akt-mediated phosphorylation. Furthermore, FOXO1 function is required for the robust activation of gluconeogenic gene expression in hepatic cells and in mouse liver by PGC-1alpha. Insulin suppresses gluconeogenesis stimulated by PGC-1alpha but co-expression of a mutant allele of FOXO1 insensitive to insulin completely reverses this suppression in hepatocytes or transgenic mice. We conclude that FOXO1 and PGC-1alpha interact in the execution of a programme of powerful, insulin-regulated gluconeogenesis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“PGC-1α is a key regulator of mitochondrial biogenesis and respiration [27] that plays a critical role in the control of metabolism and energy homeostasis [28-30].”
From PGC-1α in aging and anti-aging interventions (2009) · cites this paper as [30]
In the citing paper
“hepatic gluconeogenesis was suppressed, as witnessed by decreased expression of the FoxO1-regulated genes phosphoenolpyruvate carboxykinase (Pepck) and glucose-6-phosphatase (G6P) [72].”
From Physiologic functions of PP2A: Lessons from genetically modified mice (2019) · cites this paper as [72]
Citations
Cites
Akt Promotes Cell Survival by Phosphorylating and Inhibiting a Forkhead Transcription Factor
Brunet, A., Bonni, A., Zigmond, M. J., Lin, M. Z., Juo, P., Hu, L. S., Anderson, M. J., Arden, K. C., Blenis, J., & Greenberg, M. E. (1999) · Cell · doi:10.1016/s0092-8674(00)80595-4 · Cited by 5,594
A Cold-Inducible Coactivator of Nuclear Receptors Linked to Adaptive Thermogenesis
Puigserver, P., Wu, Z., Park, C. W., Graves, R., Wright, M., & Spiegelman, B. M. (1998) · Cell · doi:10.1016/s0092-8674(00)81410-5 · Cited by 3,864
Self-citationControl of hepatic gluconeogenesis through the transcriptional coactivator PGC-1
Yoon, J. C., Puigserver, P., Chen, G., Donovan, J., Wu, Z., Rhee, J., Adelmant, G., Stafford, J., Kahn, C. R., Granner, D. K., et al. (2001) · Nature · doi:10.1038/35093050 · Cited by 1,821
Self-citationCREB regulates hepatic gluconeogenesis through the coactivator PGC-1
Herzig, S., Long, F., Jhala, U. S., Hedrick, S., Quinn, R., Bauer, A., Rudolph, D., Schutz, G., Yoon, C., Puigserver, P., et al. (2001) · Nature · doi:10.1038/35093131 · Cited by 1,440
Self-citationREGULATION OF PHOSPHOENOLPYRUVATE CARBOXYKINASE (GTP) GENE EXPRESSION
Hanson, R. W., & Reshef, L. (1997) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.66.1.581 · Cited by 729 · cited 1×
“In contrast, insulin suppresses hepatic gluconeogenesi”
The Forkhead Transcription Factor Foxo1 Regulates Adipocyte Differentiation
Nakae, J., Kitamura, T., Kitamura, Y., Biggs, W. H., Arden, K. C., & Accili, D. (2003) · Developmental Cell · doi:10.1016/s1534-5807(02)00401-x · Cited by 727
Self-citationPhosphorylation of the Transcription Factor Forkhead Family Member FKHR by Protein Kinase B
Rena, G., Guo, S., Cichy, S. C., Unterman, T. G., & Cohen, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.24.17179 · Cited by 714
Nakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci12876 · Cited by 652
Self-citationNakae, J., Kitamura, T., Silver, D. L., & Accili, D. (2001) · Journal of Clinical Investigation · doi:10.1172/jci200112876 · Cited by 652
Self-citationNakae, J., Biggs, W. H., Kitamura, T., Cavenee, W. K., Wright, C. V. E., Arden, K. C., & Accili, D. (2002) · Nature Genetics · doi:10.1038/ng890 · Cited by 616
Self-citation
Cited by
Items 501–600 of 1,000
Yoneda, M., Hotta, K., Nozaki, Y., Endo, H., Uchiyama, T., Mawatari, H., Iida, H., Kato, S., Hosono, K., Fujita, K., et al. (2008) · BMC Gastroenterology · doi:10.1186/1471-230x-8-27 · Cited by 80
“Recent evidence also implicates PPARGC1A in the homeostatic control of systemic energy metabolism, and PPARGC1A has been shown to regulate several key hepatic gluconeogenic genes [ 31-34 ].”
BackgroundMa, D., Li, S., Lucas, E. K., Cowell, R. M., & Lin, J. D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.151688 · Cited by 73
Onuma, H., Kooi, B. T. V., Boustead, J. N., Oeser, J. K., & O’Brien, R. M. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0085 · Cited by 75
El-Sonbaty, Y. A., Suddek, G. M., Megahed, N. A., & Gameil, N. M. (2019) · Biochimie · doi:10.1016/j.biochi.2019.09.011 · Cited by 74
Hepatic FoxO1 Ablation Exacerbates Lipid Abnormalities during Hyperglycemia
Haeusler, R. A., Han, S., & Accili, D. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.134023 · Cited by 73
Self-citationGhrelin Enhances in Vivo Skeletal Muscle But Not Liver AKT Signaling in Rats
Barazzoni, R., Zanetti, M., Cattin, M. R., Visintin, L., Vinci, P., Cattin, L., Stebel, M., & Guarnieri, G. (2007) · Obesity · doi:10.1038/oby.2007.313 · Cited by 78
Santi, S. A., & Lee, H. (2011) · PLoS ONE · doi:10.1371/journal.pone.0014614 · Cited by 77
“The increase in the mitochondrial volume in Akt2-ablated cells could be due to an increase in mitochondrial biogenesis, which is regulated by components of the AMPK, FoxO, and nitric oxide pathways”
BackgroundPan, A., Sun, X., Huang, F., Liu, J., Cai, Y., Xin, W., Alolga, R. N., Li, P., Liu, B., Liu, Q., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28044-x · Cited by 77
Role of Krüppel-like factor 15 in PEPCK gene expression in the liver
Teshigawara, K., Ogawa, W., Mori, T., Matsuki, Y., Watanabe, E., Hiramatsu, R., Inoue, H., Miyake, K., Sakaue, H., & Kasuga, M. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.12.096 · Cited by 76
CITED2 links hormonal signaling to PGC-1α acetylation in the regulation of gluconeogenesis
Sakai, M., Matsumoto, M., Tujimura, T., Yongheng, C., Noguchi, T., Inagaki, K., Inoue, H., Hosooka, T., Takazawa, K., Kido, Y., et al. (2012) · Nature Medicine · doi:10.1038/nm.2691 · Cited by 77
Silent information regulator, Sirtuin 1, and age‐related diseases
Zeng, L., Chen, R., Liang, F.-X., Tsuchiya, H., Murai, H., Nakahashi, T., Iwai, K., Takahashi, T., Kanda, T., & Morimoto, S. (2009) · Geriatrics and gerontology international/Geriatrics & gerontology international · doi:10.1111/j.1447-0594.2008.00504.x · Cited by 73
Marinho, R., Ropelle, E. R., Cintra, D. E., de Souza, C. T., da Silva, A. S. R., Bertoli, F. C., Colantonio, E., D’Almeida, V., & Pauli, J. R. (2012) · Journal of Cellular Physiology · doi:10.1002/jcp.23037 · Cited by 83
“In a previous study, Puigserver et al. (2003) showed that Foxo1 and PGC-1a can physically interactwith eachother and that the combined action of PGC-1a and Foxo1 in various liver cell types results in a synergistic induction of endogenous G6Pase gene expression.”
BackgroundMethodBai, J., Greene, E., Li, W., Kidd, M. T., & Dridi, S. (2015) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201400918 · Cited by 73
PGC‐1α, a potential therapeutic target against kidney aging
Lee, G., Uddin, M. J., Kim, Y., Ko, M., Yu, I., & Ha, H. (2019) · Aging Cell · doi:10.1111/acel.12994 · Cited by 69
“The deacetylation and reac‐ tivation of PGC‐1α are mediated by SIRT1 and are associated with longevity (Canto & Auwerx, 2009; Rodgers, Lerin, Gerhart‐Hines, & Puigserver, 2008).”
BackgroundInfluentialGalbraith, L. C. A., Mui, E. J., Nixon, C., Hedley, A., Strachan, D., Mackay, G., Sumpton, D. P., Sansom, O. J., Leung, H. Y., & Ahmad, I. (2021) · Oncogene · doi:10.1038/s41388-021-01707-7 · Cited by 81
Akt‐mediated foxo1 inhibition is required for liver regeneration
Pauta, M., Rotllan, N., Fernández‐Hernando, A., Langhi, C., Ribera, J., Lu, M., Boix, L., Bruix, J., Jimenez, W., Suárez, Y., et al. (2016) · Hepatology · doi:10.1002/hep.28286 · Cited by 73
Drosophila Kruppel homolog 1 represses lipolysis through interaction with dFOXO
Kang, P., Chang, K., Liu, Y., Bouska, M. J., Birnbaum, A., Karashchuk, G., Thakore, R. V., Zheng, W., Post, S., Brent, C. S., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-16638-1 · Cited by 76
miR-378a: a new emerging microRNA in metabolism
Machado, I. F., Teodoro, J. S., Palmeira, C. M., & Rolo, A. P. (2019) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03375-z · Cited by 74
Metabolic Reprogramming in Dietary Restriction
Anderson, R. M., & Weindruch, R. (2006) · Interdisciplinary Topics in Gerontology · doi:10.1159/000096554 · Cited by 67
Regulation of Pyruvate Dehydrogenase Kinase 4 (PDK4) by Thyroid Hormone
Attia, R. R., Connaughton, S., Boone, L. R., Wang, F., Elam, M. B., Ness, G. C., Cook, G. A., & Park, E. A. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.039081 · Cited by 77
Liver Med23 ablation improves glucose and lipid metabolism through modulating FOXO1 activity
Chu, Y., Rosso, L. A. G., Huang, P., Wang, Z., Xu, Y., Xiao, Y., Bao, M., Yan, J., Song, H., & Wang, G. (2014) · Cell Research · doi:10.1038/cr.2014.120 · Cited by 74
Khan, R. I., Nirzhor, S. S. R., & Akter, R. (2018) · Biomolecules · doi:10.3390/biom8030044 · Cited by 78
“Conversely, a lower expression of SIRT6 leads to a higher amount of glucose production [88].”
BackgroundChakravarty, K., Wu, S.-Y., Chiang, C.-M., Samols, D., & Hanson, R. W. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m309905200 · Cited by 69
A highly integrated and complex PPARGC1A transcription factor binding network in HepG2 cells
Charos, A. E., Reed, B. D., Raha, D., Szekely, A. M., Weissman, S. M., & Snyder, M. (2012) · Genome Research · doi:10.1101/gr.127761.111 · Cited by 71
“Single gene studies have identified HNF4A, NR3C1 (also known as GR), and FOXO1 as key TFs that are coactivated by PPARGC1A in order to regulate downstream gluconeogenic target genes including phosphoenolpyruvate carboxykinase (PCK1) and glucose 6 phosphatase (G6PC) (Puigserver et al. 2003; Rhee et al. 2003).”
BackgroundThe role of mTOR in age-related diseases
Chrienová, Ž., Nepovimová, E., & Kuča, K. (2021) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.1080/14756366.2021.1955873 · Cited by 78
The Coactivator SRC-1 Is an Essential Coordinator of Hepatic Glucose Production
Louet, J.-F., Chopra, A. R., Sagen, J. V., An, J., York, B., Tannour-Louet, M., Saha, P. K., Stevens, R. D., Wenner, B. R., Ilkayeva, O. R., et al. (2010) · Cell Metabolism · doi:10.1016/j.cmet.2010.11.009 · Cited by 69
“While FOXO1 is known to act via PGC-1a to control hepatic glucose production (Puigserver et al., 2003), the molecular players with C/EBPa are still unknown.”
Reduced mitochondrial function in obesity-associated fatty liver: SIRT3 takes on the fat
Choudhury, M., Jonscher, K. R., & Friedman, J. E. (2011) · Aging · doi:10.18632/aging.100289 · Cited by 69
MLL1 Inhibition Reprograms Epiblast Stem Cells to Naive Pluripotency
Zhang, H., Gayen, S., Xiong, J., Zhou, B., Shanmugam, A. K., Sun, Y., Karatas, H., Liu, L., Rao, R. C., Wang, S., et al. (2016) · Cell Stem Cell · doi:10.1016/j.stem.2016.02.004 · Cited by 70
“…(e.g., Cacna2d4, Stx18, Pappa, and Dpp4) (Figure S7A, green circle) and (2) the developmental pathway as exemplified by prominent regulators of early cell lineage specification (e.g., Nerrog1, Tub, Cdh9, and Efna5) (Figures 7C and S7A, red circle) (Brennan et al., 2001; Puigserver et al., 2003).”
BackgroundSirtuins as novel players in the pathogenesis of diabetes mellitus
Turkmen, K. (2014) · World Journal of Diabetes · doi:10.4239/wjd.v5.i6.894 · Cited by 66
Kathiriya, I. S., King, I. N., Murakami, M., Nakagawa, M., Astle, J. M., Gardner, K. A., Gerard, R. D., Olson, E. N., Srivastava, D., & Nakagawa, O. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409879200 · Cited by 68
Banks, A. S., Kim-Muller, J. Y., Mastracci, T. L., Kofler, N. M., Qiang, L., Haeusler, R. A., Jurczak, M. J., Laznik, D., Heinrich, G., Samuel, V. T., et al. (2011) · Cell Metabolism · doi:10.1016/j.cmet.2011.09.012 · Cited by 67
“5 to 2-fold increases in the expression of hepatic gluconeogenetic genes, including G6pc, Pck1, and Pgc1α (Matsumoto et al., 2007; Puigserver et al., 2003) (Figure 4A).”
InfluentialSelf-citationTripathy, S., Torres‐Gonzalez, M., & Jump, D. Β. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m006080 · Cited by 75
Pathak, P., Li, T., & Chiang, J. Y. L. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.485987 · Cited by 67
“FoxO1 is known to mediate insulin signaling in regulation of gluconeogenesis and other target genes (38, 39).”
BackgroundRole of PGC-1α in exercise and fasting-induced adaptations in mouse liver
Haase, T. N., Ringholm, S., Leick, L., Biensø, R. S., Kiilerich, K., Johansen, S., Nielsen, M. M., Wojtaszewski, J. F., Hidalgo, J., Pedersen, P. A., et al. (2011) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00775.2010 · Cited by 66
Metabolic crossroads in insulin resistance: exploring lipid dysregulation and inflammation
Saadati, S., Godini, R., Reddy, A. J., Teede, H. J., & Mousa, A. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1692742 · Cited by 86
“Phosphorylation excludes FOXO1 from the nucleus, reducing gluconeogenic enzyme expression and lowering hepatic glucose production (25).”
PCAF Improves Glucose Homeostasis by Suppressing the Gluconeogenic Activity of PGC-1α
Sun, C., Wang, M., Liu, X., Luo, L., Li, K., Zhang, S., Wang, Y., Yang, Y., Ding, F., & Gu, X. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.11.029 · Cited by 67
Regulation of FOXO1-mediated transcription and cell proliferation by PARP-1
Sakamaki, J.-I., Daitoku, H., Yoshimochi, K., Miwa, M., & Fukamizu, A. (2009) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2009.03.022 · Cited by 71
Banerjee, A. K., Meyer, K., Mazumdar, B., Ray, R. B., & Ray, R. (2010) · Journal of Virology · doi:10.1128/jvi.02344-09 · Cited by 70
The longevity effect of cranberry extract in Caenorhabditis elegans is modulated by daf-16 and osr-1
Guha, S., Cao, M., Kane, R. M., Savino, A. M., Zou, S., & Dong, Y. (2012) · AGE · doi:10.1007/s11357-012-9459-x · Cited by 74
“Conversely, in the fed state, pancreatic β cells secrete insulin to inactivate FOXO1 and partially suppress gluconeogenic enzyme expression in the liver (Puigserver et al. 2003).”
BackgroundDistinctive Roles of Sirtuins on Diabetes, Protective or Detrimental?
Song, J., Yang, B., Jia, X., Li, M., Tan, W. F., Ma, S., Shi, X., & Feng, L. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00724 · Cited by 72
Yang, Z., Mi, J., Wang, Y., Xue, L., Liu, J., Fan, M., Zhang, D., Wang, L., Qian, H., & Li, Y. (2021) · Nutrition · doi:10.1016/j.nut.2021.111230 · Cited by 77
Versatile Oral Insulin Delivery Nanosystems: From Materials to Nanostructures
Wang, M., Wang, C., Ren, S., Pan, J., Wang, Y., Shen, Y., Zeng, Z., Cui, H., & Zhao, X. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23063362 · Cited by 76
Bo, T., & Fujii, J. (2024) · Molecules · doi:10.3390/molecules30010056 · Cited by 80
“Peroxisome proliferative activated receptor-γ coactivator 1 (PGC-1 α ) is a transcriptional coactivator that binds and coactivates FOXO1 and enhances the expression of gluconeogenic genes in hepatic cells [68].”
NOX4 Pathway as a Source of Selective Insulin Resistance and Responsiveness
Wu, X., & Williams, K. J. (2012) · Arteriosclerosis, Thrombosis, and Vascular Biology · doi:10.1161/atvbaha.111.244525 · Cited by 67
“As shown in Figure 1, hypolipidemic and hypoglycemic pathways downstream of AKT include translocation of facilitated glucose transporters in extrahepatic tissues(31) and AKT-mediated phosphorylations of forkhead box-1 (FOXO1) that suppress hepatic apoC-III expression(20,32) and gluconeogenesis.(33) Pathways downstream…”
miR-378 Activates the Pyruvate-PEP Futile Cycle and Enhances Lipolysis to Ameliorate Obesity in Mice
Zhang, Y., Li, C., Li, H., Song, Y., Zhao, Y., Zhai, L., Wang, H., Zhong, R., Tang, H., & Zhu, D. (2016) · EBioMedicine · doi:10.1016/j.ebiom.2016.01.035 · Cited by 65
“, 1999), and FoxO1 transcriptionally regulates Pepck, the key ratelimiting enzyme in the pyruvate-PEP futile cycle (Puigserver et al., 2003).”
BackgroundCohen, S. E., Kokkotou, E., Biddinger, S. B., Kondo, T., Gebhardt, R., Kratzsch, J., Mantzoros, C. S., & Kahn, C. R. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m704053200 · Cited by 66
FoxO1 signaling as a therapeutic target for type 2 diabetes and obesity
Benchoula, K., Arya, A., Parhar, I. S., & Wong, E. H. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173758 · Cited by 67
The Relationship between Selenoprotein P and Glucose Metabolism in Experimental Studies
Mao, J., & Teng, W. (2013) · Nutrients · doi:10.3390/nu5061937 · Cited by 67
“Moreover, insulin inhibited Sepp1 transcription via the PI3K/Akt/FoxO1a axis [53], whereas the PGC-1α-inducing glucocorticoid dexamethasone strongly enhanced Sepp1 expression and protein secretion in cultured rat hepatocytes [44]. situation of normal insulin sensitivity.”
BackgroundInfluentialKindlin-2 haploinsufficiency protects against fatty liver by targeting Foxo1 in mice
Gao, H., Zhou, L. F., Zhong, Y., Ding, Z., Lin, S., Hou, X., Zhou, X., Shao, J., Yang, F., Zou, X., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-28692-z · Cited by 68
Autophagy counters inflammation-driven glycolytic impairment in aging hematopoietic stem cells
Dellorusso, P. V., Proven, M. A., Calero‐Nieto, F. J., Wang, X., Mitchell, C. A., Hartmann, F. J., Amouzgar, M., Favaro, P. M. B., DeVilbiss, A., Swann, J. W., et al. (2024) · Cell stem cell · doi:10.1016/j.stem.2024.04.020 · Cited by 71
Forkhead Box Transcription Factor Regulation and Lipid Accumulation by Hepatitis C Virus
Bose, S. K., Kim, H., Meyer, K., Wolins, N., Davidson, N. O., & Ray, R. (2014) · Journal of Virology · doi:10.1128/jvi.03327-13 · Cited by 62
FOXO1 plays an essential role in apoptosis of retinal pericytes.
Alikhani, M., Roy, S., & Graves, D. T. (2010) · PubMed Central · Cited by 70
Xiao, N., Lou, M., Lu, Y., Yang, L., Liu, Q., Liu, B., Qi, L., & Li, P. (2017) · Diabetologia · doi:10.1007/s00125-017-4238-y · Cited by 62
Free fatty acid processing diverges in human pathologic insulin resistance conditions
Sekizkardes, H., Chung, S. T., Chacko, S. K., Haymond, M. W., Startzell, M. S., Walter, M. F., Walter, P. J., Lightbourne, M., & Brown, R. J. (2020) · Journal of Clinical Investigation · doi:10.1172/jci135431 · Cited by 68
Silva, J., Spatz, M. H., Folk, C., Chang, A., Cadenas, E., Liang, J., & Davies, D. L. (2020) · Alcohol · doi:10.1016/j.alcohol.2020.10.002 · Cited by 67
“PGC-1α is present at low but inducible levels in the liver, where it also regulates most metabolic pathways, such as fatty acid β-oxidation, gluconeogenesis, and ketogenesis (Yoon et al., 2001; Puigserver et al., 2003; Rhee et al., 2003).”
BackgroundNegative Regulators of Brown Adipose Tissue (BAT)‐Mediated Thermogenesis
Sharma, B. K., Patil, M. N., & Ande, S. (2014) · Journal of Cellular Physiology · doi:10.1002/jcp.24664 · Cited by 71
“Insulin-regulated hepatic gluconeogenesis through FOXO1-PGC-1alpha interaction.”
BackgroundRe-evaluating the FOXO1–PGC-1α connection
Schilling, M. M., Oeser, J. K., Boustead, J. N., Flemming, B. P., & O’Brien, R. M. (2006) · Nature · doi:10.1038/nature05288 · Cited by 62
Arumugam, R., Horowitz, E., Lu, D., Collier, J. J., Ronnebaum, S., Fleenor, D., & Freemark, M. (2008) · Endocrinology · doi:10.1210/en.2008-0051 · Cited by 61
“PGC1 mRNA in skeletal muscle and liver (72, 73), whereas”
BackgroundCyclin D1 Represses Gluconeogenesis via Inhibition of the Transcriptional Coactivator PGC1α
Bhalla, K., Liu, W.-J., Thompson, K. N., Anders, L., Devarakonda, S., Dewi, R. E., Buckley, S., Hwang, B., Polster, B. M., Dorsey, S. G., et al. (2014) · Diabetes · doi:10.2337/db13-1283 · Cited by 66
Nanotechnological Strategies for Protein Delivery
Villegas, M. R., Baeza, A., & Vallet‐Regí, M. (2018) · Molecules · doi:10.3390/molecules23051008 · Cited by 66
“Proteins performed essential functions, such as catalyzing biochemical reactions [1], signal transduction [2], defensive functions [3], regulatory functions [4,5], controlling cell fates [6], providing cellular and tissue structure [7,8], as molecule carriers [9–11], and maintaining a fine balance between cell surviva…”
BackgroundPrakash, P., Singh, V., Jain, M. K., Rana, M., Khanna, V., Barthwal, M. K., & Dikshit, M. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.01.038 · Cited by 65
Espinoza, D. O., Boros, L. G., Crunkhorn, S., Gami, H., & Patti, M.-E. (2010) · The FASEB Journal · doi:10.1096/fj.09-133728 · Cited by 59
“These effects may be mediated by coactivation of key transcription factors, including PPAR (1), hepatic nuclear factor 4 (2), nuclear respiratory factors (NRFs) (3), estrogen receptor-related receptor (ERR)- (official name ESRRA) (4), sterol regulatory element-binding protein 1 (5), myocyte enhancing factor 2 (6, 7),…”
BackgroundTripathy, S., & Jump, D. B. (2013) · Journal of Lipid Research · doi:10.1194/jlr.m028787 · Cited by 61
Huang, H., Muddiman, D. C., & Tindall, D. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m314143200 · Cited by 64
Leptin Deficiency and Beta-Cell Dysfunction Underlie Type 2 Diabetes in Compound Akt Knockout Mice
Chen, W. S., Peng, X.-D., Wang, Y., Xu, P.-Z., Chen, M.-L., Yongmei, L., Jeon, S., Coleman, K. G., Haschek, W. M., Bass, J. T., et al. (2009) · Molecular and Cellular Biology · doi:10.1128/mcb.01792-08 · Cited by 61
“Akt can affect hepatic glucose production by inhibiting FoxO transcription factors, since it was shown that FoxO1 elevates the expression of gluconeogenic enzymes in the liver (33).”
BackgroundThe multiple roles of salt-inducible kinases in regulating physiology
Jagannath, A., Taylor, L., Ru, Y., Wakaf, Z., Akpobaro, K., Vasudevan, S. R., & Foster, F. (2023) · Physiological Reviews · doi:10.1152/physrev.00023.2022 · Cited by 69
Fan, X., Li, X., Li, J., Zhang, Y., Wei, X., Hu, H., Zhang, B., Du, H., Zhao, M., Zhu, R., et al. (2023) · Journal of Environmental Sciences · doi:10.1016/j.jes.2023.02.040 · Cited by 64
Cao, Y., Kamioka, Y., Yokoi, N., Kobayashi, T., Hino, O., Onodera, M., Mochizuki, N., & Nakae, J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m608116200 · Cited by 66
Neuroprotection requires the functions of the RNA-binding protein HuR
Skliris, A., Papadaki, O., Kafasla, P., Karakasiliοtis, I., Hazapis, O. G., Reczko, M., Grammenoudi, S., Bauer, J., & Kontoyiannis, D. L. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.158 · Cited by 64
Kathirvel, E., Morgan, K., French, S. W., & Morgan, T. R. (2009) · European Journal of Gastroenterology & Hepatology · doi:10.1097/meg.0b013e328328f461 · Cited by 58
Yuan, Y., Shi, X., Liu, Y., & Yang, G.-S. (2010) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-010-0640-1 · Cited by 68
“As the FoxO1 protein can interact with the PGC-1a protein [ 49 ] and transfection of PGC-1a into adult fibers reduced the capacity of FoxO3 [50], FoxO1 may counteract the function of PGC-1a in this process.”
BackgroundMa, T., Liaset, B., Hao, Q., Petersen, R. K., Fjære, E., Ngo, H. T., Lillefosse, H. H., Ringholm, S., Sonne, S. B., Treebak, J. T., et al. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021647 · Cited by 59
A Novel Regulator of Type II Diabetes: MicroRNA-143
Li, B., Fan, J., & Chen, N. (2018) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2018.03.019 · Cited by 64
Cheng, F., Han, L., Xiao, Y., Pan, C., Li, Y., Ge, X., Zhang, Y., Yan, S., & Wang, M. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01253 · Cited by 59
Tissue-Specific Metabolic Regulation of FOXO-Binding Protein: FOXO Does Not Act Alone
Kodani, N., & Nakae, J. (2020) · Cells · doi:10.3390/cells9030702 · Cited by 74
Vaughan, R. A., Garcia-Smith, R., Bisoffi, M., Conn, C. A., & Trujillo, K. A. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2013.04.009 · Cited by 58
The role of genetic variants in human longevity
Chung, W., Dao, R., Chen, L., & Chung, W. (2010) · Ageing Research Reviews · doi:10.1016/j.arr.2010.08.001 · Cited by 67
“Other FOXO target genes have been shown to play roles in glucose metabolism by activating G6Pase and PEPCK (Puigserver et al., 2003), cellular differentiation and muscle atrophy by promoting catalase and MnSOD, as well as stimulating AgRP and NPY to regulate energy homeostasis (Ramaswamy et al., 2002).”
BackgroundMitochondrial dysfunction and biogenesis in the pathogenesis of Parkinson's disease.
Lin, T., Liou, C.-W., Chen, S., Chuang, Y., Tiao, M., Wang, P., Chen, J., & Chuang, J. (2009) · PubMed · Cited by 85
Bradley, R. M., & Duncan, R. E. (2018) · Current Opinion in Lipidology · doi:10.1097/mol.0000000000000492 · Cited by 58
Wan, X., Gupta, S., Zago, M. P., Davidson, M. M., Dousset, P., Amoroso, A., & Garg, N. J. (2012) · Journal of the American Heart Association · doi:10.1161/jaha.112.003855 · Cited by 68
Nutrient Sensing via mTOR in T Cells Maintains a Tolerogenic Microenvironment
Howie, D., Waldmann, H., & Cobbold, S. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00409 · Cited by 57
Ujvári, D., Jakson, I., Babayeva, S., Salamon, D., Réthi, B., Gidlöf, S. B., & Hirschberg, A. L. (2017) · PLoS ONE · doi:10.1371/journal.pone.0171004 · Cited by 60
Dröge, W., & Kinscherf, R. (2008) · Antioxidants & Redox Signaling · doi:10.1089/ars.2007.1953 · Cited by 57
“Akt1 and/or Akt2 stimulate many typically insulin-dependent functions including protein synthesis, but downregulate the autophagic/lysosomal protein catabolism, (44, 136, 183), and elicit the phosphorylation and inhibition of the forkhead transcription factor FOXO 1 (23, 152).”
Definition of the Molecular Basis for Estrogen Receptor-Related Receptor-α-Cofactor Interactions
Gaillard, S., Dwyer, M. A., & McDonnell, D. P. (2007) · Molecular Endocrinology · doi:10.1210/me.2006-0179 · Cited by 58
Liver and muscle circadian clocks cooperate to support glucose tolerance in mice
Smith, J. G., Koronowski, K. B., Mortimer, T., Sato, T., Greco, C. M., Petrus, P., Verlande, A., Chen, S., Samad, M., Deyneka, E., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112588 · Cited by 60
Wang, Y., Li, Z., He, J., & Zhao, Y. (2024) · Nutrients · doi:10.3390/nu16081102 · Cited by 64
“Puigserver et al. [95] found that the regulation of PGC-1 α in gluconeogenic procedures is primarily dependent on the interaction of PGC-1 α and FOXO1.”
BackgroundQiao, L., MacLean, P. S., You, H., Schaack, J. B., & Shao, J. (2006) · Endocrinology · doi:10.1210/en.2005-1507 · Cited by 57
Galbo, T., Olsen, G. S., Quistorff, B., & Nishimura, E. (2011) · PLoS ONE · doi:10.1371/journal.pone.0027424 · Cited by 56
Tamási, V., Monostory, K., Prough, R. A., & Falus, A. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0600-7 · Cited by 67
Once and for all, LXRα and LXRβ are gatekeepers of the endocrine system
Maqdasy, S., Trousson, A., Tauveron, I., Volle, D. H., Baron, S., & Lobaccaro, J. A. (2016) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2016.04.001 · Cited by 68
Vaughan, R. A., Garcia-Smith, R., Bisoffi, M., Trujillo, K. A., & Conn, C. A. (2012) · Nutrition and Metabolic Insights · doi:10.4137/nmi.s10233 · Cited by 55
Role of resveratrol in FOXO1-mediated gluconeogenic gene expression in the liver
Park, J.-M., Kim, T. H., Bae, J.-S., Kim, M., Kim, K., & Ahn, Y. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.11.028 · Cited by 55
“One of the pivotal transcription factors regulating gluconeogenesis is forkhead box O1 (FOXO1), which binds to insulin responsive elements (IREs) in the promoter of gluconeogenic genes [8,9].”
BackgroundWang, S., Kamat, A., Pérgola, P. E., Swamy, A., Tio, F. O., & Cusi, K. J. (2011) · Metabolism · doi:10.1016/j.metabol.2010.12.001 · Cited by 58
“[30] Puigserver P, Rhee J, Donovan J, et al.”
BackgroundSaboori, S., Koohdani, F., Nematipour, E., Rad, E. Y., Saboor‐Yaraghi, A. A., Javanbakht, M. H., Eshraghian, M., Ramezani, A., & Djalali, M. (2015) · Nutrition Metabolism and Cardiovascular Diseases · doi:10.1016/j.numecd.2015.11.013 · Cited by 64
Fatone, C., Guescini, M., Balducci, S., Battistoni, S., Settequattrini, A., Pippi, R., Stocchi, L., Mantuano, M., Stocchi, V., & De Feo, P. (2010) · Journal of Endocrinological Investigation · doi:10.1007/bf03346630 · Cited by 54
Phosphoinositides: Key modulators of energy metabolism
Bridges, D., & Saltiel, A. R. (2014) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2014.11.008 · Cited by 59
Chen, J., Wang, N., Dong, M., Guo, M., Zhao, Y., Zhuo, Z., Zhang, C., Chi, X., Pan, Y., Jiang, J., et al. (2015) · Diabetes · doi:10.2337/db15-0197 · Cited by 56
Regnault, C., Willison, J. C., Veyrenc, S., Airieau, A., Méresse, P., Fortier, M., Fournier, M., Brousseau, P., Raveton, M., & Reynaud, S. (2016) · Chemosphere · doi:10.1016/j.chemosphere.2016.04.047 · Cited by 61
Hansen, S. K., Rose, C. S., Gl�mer, C., Drivsholm, T., Borch‐Johnsen, K., J�rgensen, T., Pedersen, O. B., & Hansen, T. F. (2005) · Diabetologia · doi:10.1007/s00125-005-1671-0 · Cited by 54
“If the causal variant affects the expression or function of HNF-4α, the observed association between rs1884614 and increased fasting and post-OGTT plasma glucose levels may be explained by a combination of a defective regulation of the hepatic gluconeogenesis and a relative insulin deficiency following stimulation by…”
BackgroundRole and Regulation of Wnt/β-Catenin in Hepatic Perivenous Zonation and Physiological Homeostasis
Goel, C., Monga, S. P., & Nejak-Bowen, K. (2022) · The American Journal of Pathology · doi:10.1016/j.ajpath.2021.09.007 · Cited by 53
Metadata
- Authors
- Puigserver, P., Rhee, J., Donovan, J., Walkey, C. J., Yoon, J. C., Oriente, F., Kitamura, Y., Altomonte, J., Dong, H., Accili, D., & Spiegelman, B. M.
- Affiliations
- Harvard University (US)
- Columbia University (US)
- Icahn School of Medicine at Mount Sinai (US)
- Corresponding author
- Spiegelman, Bruce M.
- ORCID
- Venue
- Nature
- Published
- 2003-05-18
- Volume
- 423
- Issue
- 6939
- Pages
- 550-555
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1583767403
- Cited by
- 1,487
- References
- 22
- Citations by year
- 2026: 31 · 2025: 45 · 2024: 46 · 2023: 53 · 2022: 62 · 2021: 67 · 2020: 71 · 2019: 61 · 2018: 86 · 2017: 76 · 2016: 59 · 2015: 75 · 2014: 71 · 2013: 68 · 2012: 81
- FWCI
- 21.04
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springernature.com/gp/researchers/text-and-data-mining (tdm)
- www.springernature.com/gp/researchers/text-and-data-mining (vor)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Funders
- Taiho Pharmaceutical
- National Institutes of Health
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › FOXO transcription factor regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Fibroblast Growth Factor Research
- Keywords
- hepatic gluconeogenesis, insulin signaling, FOXO1, PGC-1α, transcriptional coactivation, Akt phosphorylation, fasting, diabetes mellitus, glucocorticoids, glucagon, gluconeogenic gene expression, hepatocytes, forkhead transcription factor
- MeSH terms
- Forkhead Box Protein O1, Animals, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Gluconeogenesis, Insulin, Liver, Precipitin Tests, Protein Binding, RNA, Messenger, Transcription Factors, Hepatocytes, Mice, Forkhead Transcription Factors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.